Cefuzonam
![]() | |
Systematic (IUPAC) name | |
---|---|
(6R,7R)-7-([(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-methoxyiminoacetyl]amino)-8-oxo-3-(thiadiazol-5-ylsulfanylmethyl)-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid | |
Clinical data | |
Legal status |
|
Identifiers | |
CAS Number |
82219-78-1 ![]() |
ATC code | none |
PubChem | CID 6336505 |
ChemSpider |
4891670 ![]() |
UNII |
860MT00T7T ![]() |
KEGG |
D03432 ![]() |
ChEMBL |
CHEMBL1689069 ![]() |
Chemical data | |
Formula | C16H15N7O5S4 |
Molar mass | 513.59 g/mol |
| |
| |
![]() ![]() |
Cefuzonam (INN) is a second-generation cephalosporin antibiotic.
References
- Hara K, Matsumoto F (December 1987). "[New antimicrobial agent series XXVIII: cefuzonam]". Jpn J Antibiot (in Japanese) 40 (12): 1953–63. PMID 3329242.
|
This article is issued from Wikipedia - version of the Saturday, April 02, 2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.